Position in NVAX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$43,085
+$3,605 QoQ
Shares Held
5,293
-9.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in NVAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,085 | 5,293 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $39,480 | 5,875 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $53,381 | 6,157 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $12,922 | 2,016 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $13,901 | 1,729 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,860 | 1,810 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $26,788 | 2,116 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,607 | 964 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,395 | 499 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $27,736 | 3,831 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $32,283 | 4,345 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $25,107 | 3,623 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,168 | 600 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,768 | 262 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $17,949 | 349 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $19,296 | 262 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $24,321 | 170 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $46,852 | 226 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $35,243 | 166 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $19,037 | 105 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,697 | 78 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,751 | 90 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,501 | 78 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||